ストックスクリーナーアプリを入手
1.28
0.00%
0.00
プレマーケット:
1.27
-0.01
-0.78%
前日終値:
$1.28
開ける：
$1.27
24時間の取引高:
468.26K
Relative Volume:
0.91
時価総額：
$44.55M
収益：
$2.91M
当期純損益:
$-220.40M
株価収益率:
-0.3516
EPS:
-3.64
ネットキャッシュフロー:
$-176.15M
1週間 パフォーマンス:
-5.88%
1か月 パフォーマンス:
+9.40%
6か月 パフォーマンス:
-25.15%
1年 パフォーマンス:
-88.08%
1日の値動き範囲:
$1.2625
$1.29
1週間の範囲:
$1.26
$1.365
52週間の値動き範囲:
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
名前
Igm Biosciences Inc
セクター
電話
650-965-7873
住所
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.28 | 81.86M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2025-01-10 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-10-01 | ダウングレード | Truist | Buy → Hold |
| 2024-02-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | 再開されました | Jefferies | Buy |
| 2022-10-17 | 開始されました | JP Morgan | Neutral |
| 2022-08-29 | 開始されました | BofA Securities | Buy |
| 2021-12-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | アップグレード | Wedbush | Neutral → Outperform |
| 2021-08-26 | 開始されました | Morgan Stanley | Overweight |
| 2021-01-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-22 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-07-17 | 開始されました | Robert W. Baird | Outperform |
| 2020-07-01 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-28 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Wedbush | Outperform |
| 2019-10-14 | 開始されました | Guggenheim | Buy |
| 2019-10-14 | 開始されました | Jefferies | Buy |
| 2019-10-14 | 開始されました | Piper Jaffray | Overweight |
| 2019-10-14 | 開始されました | Stifel | Buy |
すべてを表示
Igm Biosciences Inc (IGMS) 最新ニュース
IGM Biosciences Inc. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.9%Here's What Happened - MarketBeat
What analysts say about IGM Biosciences Inc. stockHigh-velocity capital appreciation - PrintWeekIndia
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
What drives IGM Biosciences Inc. stock priceConsistently exceptional gains - jammulinksnews.com
Is IGM Biosciences Inc. a good long term investmentFree Stock Market Real-Time Monitoring - jammulinksnews.com
Fierce Biotech Layoff Tracker 2025: Sail shrinks crew again; Sarepta lays off 500 staffers - Fierce Biotech
IGM Biosciences (NASDAQ:IGMS) Trading Down 5.9% – Here’s Why - Defense World
Why IGM Biosciences Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Concentra Group (CON) to Acquire IGM Biosciences - MSN
What makes IGM Biosciences Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
How IGM Biosciences Inc. stock performs during market volatilityFree Access to Group - Newser
In Brief: Concentra Snaps Up Struggling IGM Biosciences In Latest Biotech Deal - insights.citeline.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP - The Malaysian Reserve
IGM Biosciences to be acquired by Concentra - The Pharma Letter
Regeneron bispecific approved for myeloma; Concentra to buy IGM - BioPharma Dive
Concentra to acquire IGM Biosciences for $1.247 per share plus CVR - Investing.com Nigeria
Concentra Biosciences, LLC agreed to acquire IGM Biosciences, Inc. for $76.3 million. - MarketScreener
IGM Biosciences Shares Surge on Takeover Agreement with Concentra - MSN
IGM Biosciences Gets Snapped Up In Concentra Deal - Finimize
IGM Biosciences stock soars after Concentra acquisition deal - Investing.com
IGM Biosciences Enters Definitive Merger Agreement with Concentra Biosciences for Acquisition - Nasdaq
IGM Biosciences stock soars after Concentra acquisition deal By Investing.com - Investing.com UK
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from Russell 3000 Index - MarketScreener
Igm biosciences CFO Tahir Misbah sells $1,825 in stock - Investing.com
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
IGM Biosciences price target lowered to $1 from $2 at Truist - Yahoo Finance
IGM Biosciences Faces Nasdaq Non-Compliance Notice - TipRanks
Truist Revises IGM Biosciences (IGMS) Price Target to $1 | IGMS Stock News - GuruFocus
Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating - MarketScreener
IGM Biosciences (NASDAQ:IGMS) Cut to "Sell" at Wall Street Zen - MarketBeat
Millennium Management LLC Sells 69,074 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
Two Sigma Investments LP Grows Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Igm Biosciences Inc (IGMS) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.17%
大文字化:
|
ボリューム (24 時間):